Dorien Leenaerts

Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin‐activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different in vitro models

Dorien Leenaerts, Stéphane Loyau, Joachim C. Mertens et al. · Journal of Thrombosis and Haemostasis · 2018 · 19 citations · Full text

Medicine, Biochemistry, Molecular Biology +14

Plasma levels of carboxypeptidase U (CPU, CPB2 or TAFIa) are elevated in patients with acute myocardial infarction

Dorien Leenaerts, Johan Bosmans, Pieter Van der Veken et al. · Journal of Thrombosis and Haemostasis · 2015 · 18 citations

Medicine, Cardiology, Internal Medicine +12

Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood–brain barrier dysfunction

Joachim C. Mertens, Dorien Leenaerts, Raf Brouns et al. · Journal of Thrombosis and Haemostasis · 2017 · 18 citations · Full text

Life Sciences, Neurology, Neuroscience +16

Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis

Dorien Leenaerts, Jef Aernouts, Pieter Van der Veken et al. · Thrombosis and Haemostasis · 2017 · 14 citations

Life Sciences, Biochemistry, Molecular Biology +14

Inhibition of the procarboxypeptidase U (proCPU, TAFI, proCPB2) system due to hemolysis

Joachim C. Mertens, Karen Claesen, Dorien Leenaerts et al. · Journal of Thrombosis and Haemostasis · 2019 · 10 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +9